aTyr Pharma Inc Reports Results for Quarter Ended June 30, 2026

What Happened
aTyr Pharma, Inc. announced financial results for the quarter ended June 30, 2026 via a press release issued August 7, 2026. The company filed a Form 8-K (Item 2.02) to report the results and furnished the press release as an exhibit to the filing.

Key Details

• Form 8-K filed August 7, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• Financial results cover the quarter ended June 30, 2026.
• Press release is furnished as Exhibit 99.1 and is incorporated by reference in the 8-K.
• The filing also includes the Cover Page Interactive Data File (Exhibit 104).

Why It Matters
This 8-K is the company’s timely disclosure of its quarterly results (earnings, revenue and related metrics will be in the press release). Retail investors should read the attached press release for the specific financial figures, trends, and any management commentary, and watch for the subsequent quarterly report (Form 10-Q) for full financial statements and additional detail.